Aytu BioPharma, Inc. (AYTU)
Sells prescription medications for ADHD and children's allergies and vitamins.
$2.13+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-11.2%
The outlook
AYTU is trading well below its 50- and 200-day moving averages, sitting in the lower third of its 52-week range. Analyst sentiment skews bearish overall, though the average price target sits notably above the current price. The stock remains volatile and positioned toward the weaker end of recent trading activity.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range34% of the way from its 52-week low to high
Price targetAvg target +346% vs current price
Analyst price target
~12-month · 3 analysts$9.50average target+346.0% vs now
Now $2.13
Low $7.00High $14.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$22.9M
52-wk high
$3.07
52-wk low
$1.65
50-day avg
$2.18
200-day avg
$2.37
Trailing P/E
—